|
|
|
|
Дата |
|---|
| 10:20 |
| 04.08.2025 |
| 01.08.2025 |
| 31.07.2025 |
| 30.07.2025 |
| 29.07.2025 |
| 28.07.2025 |
| 25.07.2025 |
| 24.07.2025 |
| 23.07.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
31.28
|
31.29
|
32.12
|
30.01
|
32.16
|
31.28
|
|
|
1 245 528 501.00
|
|
|
|
|
32.12
|
30.01
|
32.16
|
31.28
|
|
|
1 245 528 501.00
|
|
|
|
|
31.93
|
31.49
|
33.10
|
32.26
|
|
|
1 087 007 462.00
|
|
|
|
|
32.70
|
31.70
|
33.68
|
31.91
|
|
|
1 382 519 372.00
|
|
|
|
|
34.10
|
32.28
|
37.06
|
33.42
|
|
|
2 092 056 582.00
|
|
|
|
|
31.77
|
30.94
|
35.20
|
35.18
|
|
|
1 651 248 753.00
|
|
|
|
|
29.90
|
29.43
|
32.54
|
32.00
|
|
|
1 264 876 772.00
|
|
|
|
|
28.06
|
27.86
|
30.65
|
29.90
|
|
|
1 407 943 600.00
|
|
|
|
|
27.00
|
26.83
|
28.50
|
28.48
|
|
|
1 252 947 018.00
|
|
|
|
|
25.99
|
25.69
|
28.25
|
27.33
|
|
|
1 595 748 759.00
|
|
Период |
|---|
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
31.07.2024
|
30.07.2024 |
0.16 CNY |
|
25.07.2023
|
24.07.2023 |
0.4 CNY |
|
08.08.2022
|
05.08.2022 |
0.36 CNY |
|
05.08.2021
|
04.08.2021 |
0.35 CNY |
|
08.06.2020
|
05.06.2020 |
0.34 CNY |
|
10.04.2019
|
09.04.2019 |
0.3 CNY |
|
31.05.2018
|
30.05.2018 |
0.3 CNY |
Joinn Laboratories (China) Co Ltd is a China-based company principally engaged in the provision of pharmaceutical research and development outsourcing services. The Company operates its business through two segments. The Pharmaceutical Research and Development Outsourcing Services segment mainly provides non-clinical safety evaluation services, pharmacodynamic research services, animal pharmacokinetic research services and drug screening services. The Laboratory Animal Production and Marketing segment is principally engaged in the production and sales of laboratory animals such as mice, rats and monkeys as well as their ancillary products.
